Suplatast tosylate (CAS 94055-76-2)

Suplatast tosylate functions as a selective phosphodiesterase 4 (PDE4) inhibitor. It exerts its mechanism of action by inhibiting the PDE4 enzyme, which plays a role in the hydrolysis of cyclic adenosine monophosphate (cAMP) within cells. By inhibiting PDE4, suplatast tosylate increases intracellular levels of cAMP, leading to downstream effects on various cellular processes. Suplatast Tosylate modulates inflammatory and immune responses by affecting the production of inflammatory mediators and cytokines. Suplatast tosylate may influence the function of immune cells, such as T lymphocytes and macrophages, by altering their activation and cytokine production. Its mechanism of action at the molecular level involves interactions with specific binding sites on the PDE4 enzyme, leading to the modulation of intracellular signaling pathways. Suplatast tosylate′s function as a PDE4 inhibitor allows for the modulation of cellular responses and signaling pathways involved in inflammatory and immune processes.